Skip to main content
. 2024 Jun 28;17(4):e004415. doi: 10.1161/CIRCGEN.123.004415

Figure 4.

Figure 4.

TET2 (ten eleven translocase 2) clonal hematopoiesis of indeterminate potential (CHIP) demonstrates more severe coronary artery disease (CAD). Fifty percent of patients with multiple CHIP mutations have a TET2 mutation. Adjusted odds ratios for angiography outcomes stratified by CHIP gene mutation. Numeric data are displayed as percentage (N) for binary outcomes, and median (interquartile range) for continuous data. LAD indicates left anterior descending; and LM, left main.